COLTENE (CLTN) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
20 Feb, 2026Executive summary
Net sales for H1 2024 reached CHF 127.5 million, down 3% year-over-year, but nearly flat in local currency, reflecting resilience amid currency headwinds.
Profitability improved versus H2 2023, with gross margin rising to 66.6% and EBIT margin at 10.2%, though EBIT was down 10% year-over-year.
Net income increased to CHF 10.4 million, up 3.9% year-over-year, aided by a better financial result and lower tax rate.
Free cash flow remained strong at CHF 13.8 million, despite being lower than CHF 16.7 million in H1 2023, and cash balance increased by 51.6%.
Strategic focus on innovation, digital marketing, operational excellence, and leadership changes, with new product launches and sustainability initiatives underway.
Financial highlights
Net sales declined 3% year-over-year to CHF 127.5 million, but only 0.7% in local currency.
EBIT margin was 10.2%, down from 11.0% last year; gross margin improved to 66.6% from 65.4% due to product mix and procurement.
Net income rose to CHF 10.4 million, with a profit margin of 8.2%.
Operating cash flow reached CHF 16.5 million, down 20% year-over-year due to prior period's higher net working capital impact.
Net debt reduced to CHF 24.1 million as of June 30, 2024.
Outlook and guidance
Positive growth of 3%-5% in local currency expected for 2024, supported by normalized dealer inventories and momentum from H1.
Midterm target for sustainable EBIT margin remains at 15%.
Strategy process for 2025–2027 underway, with results to be presented in October 2024.
Dividend payout ratio target remains at about 70%, with a sustainable long-term dividend policy.
Market expected to remain flat, but company aims to grow above market and gain share.
Latest events from COLTENE
- Net profit fell 27% and EBIT margin dropped to 8.8%, with growth and margin recovery targeted for 2026.CLTN
H2 202513 Mar 2026 - Aims for 3–5% annual growth, 13–15% EBIT margin by 2027, and leadership in dental innovation.CLTN
CMD 2024 Presentation20 Feb 2026 - Net profit surged 71% to CHF 20.5m, with EBIT margin up to 10.7% and strong cash flow.CLTN
H2 202420 Feb 2026 - Sales and profit dropped sharply, but recovery is expected in the second half.CLTN
H1 202520 Feb 2026